Episurf Medical AB (publ) (FRA:16E)
Germany
· Delayed Price · Currency is EUR 0.0001
-0.0010 (-90.91%)
At close: Dec 4, 2025
Episurf Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 21.7 | 50.5 | 57.9 | 155.3 | 237.9 | 155 | Upgrade
|
| Cash & Short-Term Investments | 21.7 | 50.5 | 57.9 | 155.3 | 237.9 | 155 | Upgrade
|
| Cash Growth | -67.52% | -12.78% | -62.72% | -34.72% | 53.48% | 512.65% | Upgrade
|
| Accounts Receivable | 5.2 | 2.2 | 1.4 | 1.9 | 1.6 | 0.6 | Upgrade
|
| Other Receivables | 1 | 3.7 | 1.8 | 2 | 2.4 | 2.4 | Upgrade
|
| Receivables | 6.2 | 5.9 | 3.2 | 3.9 | 4 | 3 | Upgrade
|
| Inventory | 3.1 | 3.2 | 3.7 | 1.9 | 1.9 | 2 | Upgrade
|
| Prepaid Expenses | - | 0.2 | 0.2 | - | 0.5 | 0.4 | Upgrade
|
| Other Current Assets | 2.8 | -0.1 | - | -0.1 | 0.1 | -0.1 | Upgrade
|
| Total Current Assets | 33.8 | 59.7 | 65 | 161 | 244.4 | 160.3 | Upgrade
|
| Property, Plant & Equipment | 5.9 | 2.8 | 5.6 | 6.7 | 3.3 | 3.8 | Upgrade
|
| Long-Term Investments | - | - | - | - | - | 0.5 | Upgrade
|
| Other Intangible Assets | 10.5 | 11.4 | 12.2 | 13.6 | 14.1 | 14.1 | Upgrade
|
| Long-Term Deferred Charges | 26.5 | 23.9 | 21.5 | 15.9 | 9 | 6.7 | Upgrade
|
| Other Long-Term Assets | -0.1 | - | - | - | -0.2 | - | Upgrade
|
| Total Assets | 76.6 | 97.8 | 104.3 | 197.2 | 270.6 | 185.4 | Upgrade
|
| Accounts Payable | 4.9 | 3.2 | 6.1 | 4.4 | 5.9 | 5.4 | Upgrade
|
| Accrued Expenses | 2.5 | 7.6 | 7.6 | 7.2 | 5.9 | 5.7 | Upgrade
|
| Current Portion of Leases | 3.2 | 2.3 | 2.9 | 2.5 | 2.1 | 2.4 | Upgrade
|
| Other Current Liabilities | 1.7 | 0.8 | 0.8 | 0.6 | 0.3 | 0.4 | Upgrade
|
| Total Current Liabilities | 12.3 | 13.9 | 17.4 | 14.7 | 14.2 | 13.9 | Upgrade
|
| Long-Term Leases | 2.5 | - | 2.3 | 3.8 | 0.8 | 1.5 | Upgrade
|
| Other Long-Term Liabilities | - | 0.1 | 0.1 | 1 | 2.8 | 0.5 | Upgrade
|
| Total Liabilities | 14.8 | 14 | 19.8 | 19.5 | 17.8 | 15.9 | Upgrade
|
| Common Stock | 16.6 | 6.5 | 80.2 | 80.1 | 80 | 66.7 | Upgrade
|
| Additional Paid-In Capital | 845.6 | 832.6 | 684.8 | 684.8 | 684.4 | 546.2 | Upgrade
|
| Retained Earnings | -800.3 | -755.2 | -680.2 | -587 | -511.3 | -443.2 | Upgrade
|
| Comprehensive Income & Other | -0.1 | -0.1 | -0.3 | -0.2 | -0.3 | -0.2 | Upgrade
|
| Shareholders' Equity | 61.8 | 83.8 | 84.5 | 177.7 | 252.8 | 169.5 | Upgrade
|
| Total Liabilities & Equity | 76.6 | 97.8 | 104.3 | 197.2 | 270.6 | 185.4 | Upgrade
|
| Total Debt | 5.7 | 2.3 | 5.2 | 6.3 | 2.9 | 3.9 | Upgrade
|
| Net Cash (Debt) | 16 | 48.2 | 52.7 | 149 | 235 | 151.1 | Upgrade
|
| Net Cash Growth | -74.88% | -8.54% | -64.63% | -36.60% | 55.53% | 678.87% | Upgrade
|
| Net Cash Per Share | 0.02 | 0.10 | 0.17 | 0.56 | 1.04 | 0.93 | Upgrade
|
| Filing Date Shares Outstanding | 1,660 | 651.48 | 267.07 | 266.91 | 266.54 | 222.04 | Upgrade
|
| Total Common Shares Outstanding | 1,660 | 651.48 | 267.07 | 266.91 | 266.54 | 222.04 | Upgrade
|
| Working Capital | 21.5 | 45.8 | 47.6 | 146.3 | 230.2 | 146.4 | Upgrade
|
| Book Value Per Share | 0.04 | 0.13 | 0.32 | 0.67 | 0.95 | 0.76 | Upgrade
|
| Tangible Book Value | 51.3 | 72.4 | 72.3 | 164.1 | 238.7 | 155.4 | Upgrade
|
| Tangible Book Value Per Share | 0.03 | 0.11 | 0.27 | 0.61 | 0.90 | 0.70 | Upgrade
|
| Machinery | - | 0.5 | 0.5 | 0.9 | 0.9 | 0.8 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.